ACR Meeting Abstracts
Abstract Number: 876 • ACR/ARHP Annual Meeting 2016
Richard Conway1, Lorraine O'Neill2, Phil Gallagher3, Eileen O'Flynn4, Geraldine M. McCarthy5, Conor Murphy6, Douglas J. Veale7, Ursula Fearon8 and Eamonn S. Molloy9, 1CARD Newman Research Fellow, University College Dublin, Dublin, Ireland, 2Rheumatology, St. Vincent's University Hospital, Dublin, Ireland, 3St. Vincent's University Hospital, Department of Rheumatology, Dublin, Ireland, 4Rheumatology, Dublin Academic Medical Centre, St. Vincent's University Hospital, Dublin, Ireland, 5Div of Rheumatology, Mater Misericordiae University Hospital, Dublin, Ireland, 6Department of Ophthalmology, Royal Victoria Eye and Ear Hospital, Dublin, Ireland, 7Centre for Arthritis and Rheumatic Diseases, Dublin Academic Medical Centre, University College Dublin, Dublin 4, Ireland, 8Trinity College Dublin, Department of Molecular Rheumatology, Trinity College Dublin, Dublin, Ireland, 9Rheumatology, Centre for Arthritis and Rheumatic Diseases, Dublin Academic Medical Centre, St Vincent's University Hospital, Dublin, Ireland
Background/Purpose: Giant cell arteritis (GCA) requires treatment with high dose corticosteroids with attendant significant adverse events. There is a critical need for alternative therapies. Interleukins…